Dr. David Ko, MD

NPI: 1568405470
Total Payments
$16,454
2023 Payments
$8,430
Companies
15
Transactions
76
Medicare Patients
2,263
Medicare Billing
$261,043

Payment Breakdown by Category

Other$7,805 (47.4%)
Consulting$5,631 (34.2%)
Food & Beverage$1,997 (12.1%)
Travel$995.09 (6.0%)
Education$26.73 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,805 4 47.4%
Consulting Fee $5,631 2 34.2%
Food and Beverage $1,997 64 12.1%
Travel and Lodging $995.09 5 6.0%
Education $26.73 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $15,349 17 $0 (2023)
Janssen Pharmaceuticals, Inc $222.65 19 $0 (2018)
Merck Sharp & Dohme LLC $178.20 5 $0 (2023)
AbbVie Inc. $154.92 3 $0 (2021)
PFIZER INC. $128.19 11 $0 (2017)
Lundbeck LLC $93.03 2 $0 (2017)
Boehringer Ingelheim Pharmaceuticals, Inc. $69.92 4 $0 (2017)
Novartis Pharmaceuticals Corporation $54.68 3 $0 (2017)
Amgen Inc. $53.79 3 $0 (2017)
GlaxoSmithKline, LLC. $31.44 2 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2023 $8,430 11 Astellas Pharma US Inc ($8,261)
2022 $4,564 5 Astellas Pharma US Inc ($4,564)
2021 $124.99 1 AbbVie Inc. ($124.99)
2020 $2,506 3 Astellas Pharma US Inc ($2,506)
2018 $47.67 3 Sunovion Pharmaceuticals Inc. ($29.10)
2017 $780.32 53 Janssen Pharmaceuticals, Inc ($204.08)

All Payment Transactions

76 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
09/21/2023 Eisai Inc. Leqembi (Drug) Education Cash or cash equivalent $26.73 General
Category: Neurology
09/20/2023 Astellas Pharma US Inc Veozah (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,735.00 General
Category: Biological
09/20/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Biological
08/30/2023 Astellas Pharma US Inc Veozah (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,080.00 General
Category: Biological
08/30/2023 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $117.74 General
Category: Biological
08/30/2023 Astellas Pharma US Inc Veozah (Drug) Travel and Lodging Cash or cash equivalent $110.04 General
Category: Biological
07/18/2023 Astellas Pharma US Inc Veozah (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $520.00 General
Category: Biological
06/01/2023 Astellas Pharma US Inc Veozah (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,470.00 General
Category: Biological
06/01/2023 Astellas Pharma US Inc Veozah (Drug) Travel and Lodging Cash or cash equivalent $103.53 General
Category: Biological
01/25/2023 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $124.88 General
Category: CARDIOVASCULAR
01/24/2023 Merck Sharp & Dohme LLC STEGLATRO (Drug), VERQUVO, VERQUVO Food and Beverage In-kind items and services $17.54 General
Category: ENDOCRINOLOGY
11/18/2022 Astellas Pharma US Inc Consulting Fee Cash or cash equivalent $3,396.00 General
11/18/2022 Astellas Pharma US Inc Food and Beverage In-kind items and services $299.75 General
11/17/2022 Astellas Pharma US Inc Travel and Lodging Cash or cash equivalent $607.20 General
11/17/2022 Astellas Pharma US Inc Travel and Lodging Cash or cash equivalent $138.32 General
11/17/2022 Astellas Pharma US Inc Food and Beverage In-kind items and services $123.22 General
07/15/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $124.99 General
Category: NEUROSCIENCE
03/06/2020 Astellas Pharma US Inc Consulting Fee Cash or cash equivalent $2,235.00 General
03/06/2020 Astellas Pharma US Inc Food and Beverage In-kind items and services $235.46 General
03/06/2020 Astellas Pharma US Inc Travel and Lodging Cash or cash equivalent $36.00 General
12/19/2018 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $13.89 General
Category: Respiratory
11/29/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug), INVOKANA Food and Beverage In-kind items and services $18.57 General
Category: Cardiovascular & Metabolism
11/26/2018 Sunovion Pharmaceuticals Inc. LONHALA MAGNAIR (Drug) Food and Beverage In-kind items and services $15.21 General
Category: Respiratory
12/07/2017 AbbVie, Inc. Androgel (Drug), Synthroid Food and Beverage In-kind items and services $14.93 General
Category: Endocrinology
12/05/2017 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $23.03 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 540 887 $166,956 $61,938
2022 9 544 923 $177,041 $64,572
2021 10 589 951 $203,741 $73,471
2020 9 590 939 $201,440 $61,063
Total Patients
2,263
Total Services
3,700
Medicare Billing
$261,043
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 212 297 $48,606 $20,625 42.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 145 283 $30,778 $13,840 45.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 41 135 $36,585 $12,457 34.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 48 61 $32,147 $8,626 26.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 45 58 $16,356 $5,358 32.8%
99442 Telephone medical discussion with physician, 11-20 minutes Facility 2023 16 17 $1,836 $836.02 45.5%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 33 36 $648.00 $195.17 30.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 246 400 $68,088 $28,081 41.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 34 148 $40,108 $12,531 31.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 128 215 $25,179 $10,648 42.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 28 38 $20,026 $5,868 29.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 24 32 $9,024 $2,804 31.1%
99220 Initial hospital observation care per day, typically 70 minutes Facility 2022 14 17 $8,228 $2,523 30.7%
99442 Telephone medical discussion with physician, 11-20 minutes Facility 2022 27 28 $3,117 $1,107 35.5%
99217 Hospital observation care on day of discharge Facility 2022 13 14 $2,674 $817.93 30.6%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2022 30 31 $598.00 $192.78 32.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 241 386 $74,974 $30,436 40.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 43 156 $42,276 $13,472 31.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 128 206 $28,629 $10,654 37.2%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 39 45 $23,715 $7,392 31.2%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 37 47 $13,254 $4,118 31.1%
99220 Hospital observation care, typically 70 minutes Facility 2021 17 18 $8,712 $2,735 31.4%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 21 21 $6,845 $2,271 33.2%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2021 27 34 $2,278 $1,450 63.7%
99217 Hospital observation care on day of discharge Facility 2021 13 13 $2,483 $787.28 31.7%

About Dr. David Ko, MD

Dr. David Ko, MD is a Internal Medicine healthcare provider based in Rancho Mirage, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568405470.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ko, MD has received a total of $16,454 in payments from pharmaceutical and medical device companies, with $8,430 received in 2023. These payments were reported across 76 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,805).

As a Medicare-enrolled provider, Ko has provided services to 2,263 Medicare beneficiaries, totaling 3,700 services with total Medicare billing of $261,043. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Rancho Mirage, CA
  • Active Since 06/14/2006
  • Last Updated 12/27/2017
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1568405470

Products in Payments

  • Veozah (Drug) $8,261
  • XARELTO (Drug) $201.14
  • UBRELVY (Drug) $124.99
  • VERQUVO (Drug) $124.88
  • ONFI (Drug) $93.03
  • STIOLTO (Drug) $69.92
  • VIAGRA (Drug) $67.29
  • Prolia (Biological) $53.79
  • ENTRESTO (Drug) $36.77
  • ANORO (Drug) $31.44
  • Androgel (Drug) $29.93
  • LONHALA MAGNAIR (Drug) $29.10
  • VIVLODEX (Drug) $27.27
  • ELIQUIS (Drug) $26.98
  • Leqembi (Drug) $26.73
  • LYRICA (Drug) $24.57
  • ASMANEX (Drug) $23.64
  • INVOKANA (Drug) $21.51
  • COSENTYX (Biological) $17.91
  • XIFAXAN (Drug) $17.70

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Rancho Mirage